title: ECCO Position Statement on the Use of Biosimilars for Inflammatory Bowel Disease-An Update.
authors.affiliation: ECCO Governing Board; IBD Center, Humanitas Research Hospital, Rozzano, Milan, Italy sdanese@hotmail.com.|Department of Biomedical Sciences, Humanitas University, Rozzano, Milan, Italy.
authors.forename: Silvio
authors.initials: S
authors.lastname: Danese
authors.affiliation: ECCO GuiCom; IBD Center, Humanitas Research Hospital, Rozzano, Milan, Italy.
authors.forename: Gionata
authors.initials: G
authors.lastname: Fiorino
authors.affiliation: Y-ECCO; Department of Medicine, University of Cambridge, Cambridge, UK.
authors.forename: Tim
authors.initials: T
authors.lastname: Raine
authors.affiliation: ECCO ClinCom; Department of Gastroenterology and Hepatology, University Hospitals Leuven, Leuven, Belgium.
authors.forename: Marc
authors.initials: M
authors.lastname: Ferrante
authors.affiliation: N-ECCO; University of Manchester/Manchester Royal Infirmary, School for Nursing/Gastroenterology, Manchester, UK.
authors.forename: Karen
authors.initials: K
authors.lastname: Kemp
authors.affiliation: P-ECCO; Department of Gastroenterology, Hepatology, Feeding Disorders and Peadiatrics, Children's Memorial Health Institute, Warsaw, Poland.
authors.forename: Jaroslaw
authors.initials: J
authors.lastname: Kierkus
authors.affiliation: ECCO EduCom; 1st Department of Medicine, Semmelweis University, Budapest, Hungary.
authors.forename: Peter L
authors.initials: PL
authors.lastname: Lakatos
authors.affiliation: ECCO Governing Board; Department of Gastroenterology, Evangelismos Hospital, Athens, Greece.
authors.forename: Gerassimos
authors.initials: G
authors.lastname: Mantzaris
authors.affiliation: ECCO SciCom; Department of Gastroenterology & Hepatology, Erasmus Medical Center, Rotterdam, The Netherlands.
authors.forename: Janneke
authors.initials: J
authors.lastname: van der Woude
authors.affiliation: ECCO Governing Board; University Hospital Clínic de Barcelona, Barcelona, Spain.
authors.forename: Julian
authors.initials: J
authors.lastname: Panes
authors.affiliation: ECCO Governing Board; Gastroenterology and Inserm U954, University Hospital of Nancy, Nancy, France.
authors.forename: Laurent
authors.initials: L
authors.lastname: Peyrin-Biroulet
mesh_terms: D059451:Biosimilar Pharmaceuticals / Q000627:therapeutic use*; D057915:Drug Substitution / Q000592:standards; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy*; D000069285:Infliximab / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D059451:Biosimilar Pharmaceuticals; D005765:Gastrointestinal Agents; D000069285:Infliximab